Klotz, L. et al. 2017. Testosterone suppression in the treatment of recurrent or metastatic prostate cancer — A Canadian consensus statement. Canadian Urological Association Journal. 12, 2 (Dec. 2017), 30–7. DOI:https://doi.org/10.5489/cuaj.5116.